- Home
- ARQQ vs CDNA Comparison
ARQQ vs CDNA Comparison
Compare ARQQ & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQQ
- CDNA
- Stock Information
- Founded
- ARQQ 2017
- CDNA 1998
- Country
- ARQQ United Kingdom
- CDNA United States
- Employees
- ARQQ 82
- CDNA N/A
- Industry
- ARQQ Computer Software: Prepackaged Software
- CDNA Medical Specialities
- Sector
- ARQQ Technology
- CDNA Health Care
- Exchange
- ARQQ Nasdaq
- CDNA Nasdaq
- Market Cap
- ARQQ 622.8M
- CDNA 712.2M
- IPO Year
- ARQQ N/A
- CDNA 2014
- Fundamental
- Price
- ARQQ $36.05
- CDNA $15.75
- Analyst Decision
- ARQQ Strong Buy
- CDNA Buy
- Analyst Count
- ARQQ 1
- CDNA 8
- Target Price
- ARQQ $60.00
- CDNA $26.86
- AVG Volume (30 Days)
- ARQQ 962.4K
- CDNA 1.0M
- Earning Date
- ARQQ 12-04-2025
- CDNA 11-04-2025
- Dividend Yield
- ARQQ N/A
- CDNA N/A
- EPS Growth
- ARQQ N/A
- CDNA N/A
- EPS
- ARQQ 0.48
- CDNA 1.00
- Revenue
- ARQQ $241,000.00
- CDNA $340,826,000.00
- Revenue This Year
- ARQQ $86.94
- CDNA $12.73
- Revenue Next Year
- ARQQ $1,017.32
- CDNA $11.90
- P/E Ratio
- ARQQ $87.36
- CDNA $14.56
- Revenue Growth
- ARQQ N/A
- CDNA 14.72
- 52 Week Low
- ARQQ $5.22
- CDNA $10.96
- 52 Week High
- ARQQ $62.00
- CDNA $26.37
- Technical
- Relative Strength Index (RSI)
- ARQQ 42.41
- CDNA 57.18
- Support Level
- ARQQ $41.50
- CDNA $14.27
- Resistance Level
- ARQQ $46.01
- CDNA $15.29
- Average True Range (ATR)
- ARQQ 4.00
- CDNA 0.73
- MACD
- ARQQ -1.15
- CDNA 0.00
- Stochastic Oscillator
- ARQQ 16.47
- CDNA 53.24
About ARQQ Arqit Quantum Inc.
Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product SKA-Platform. The firm operates in one segment that is, the provision of cybersecurity services. The company operates and generates its revenue from UK.
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.